The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Create account Sign in

Clinical research

Multivessel versus culprit vessel percutaneous coronary intervention in ST-elevation myocardial infarction: is more worse?

EuroIntervention 2013;9:909-915. DOI: 10.4244/EIJV9I8A153

Milosz Jaguszewski
Milosz Jaguszewski1, MD; Dragana Radovanovic2, MD; Brahmajee K. Nallamothu3, MD; Thomas F. Lüscher1, MD; Philip Urban4, MD; Franz R. Eberli5, MD; Osmund Bertel6, MD; Giovanni B. Pedrazzini7, MD; Stephan Windecker8, MD; Raban Jeger9, MD; Paul Erne2,10*, MD; for the AMIS Plus Investigators
1. Department of Cardiology, University Hospital Zurich, Zurich, Switzerland; 2. AMIS Plus Data Center, Institute of Social and Preventive Medicine, University of Zurich, Zurich, Switzerland; 3. Division of Cardiovascular Diseases, Un

Aims: We examined what type of STEMI patients are more likely to undergo multivessel PCI (MPCI) in a “real-world” setting and whether MPCI leads to worse or

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

multivessel pcistemi
Share on Facebook Share on Twitter Share on Linkedin

Read next article

Single-vessel or multivessel PCI in patients with multivessel disease presenting with non-ST-elevation acute coronary syndromes

Latest news

New issue
Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue
(Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right))
December 6, 2019
Trials Book
Discover 5 new trials: GALILEO, CONDI-2/ERIC-PCI, EVOLUTE II-5 years, SCOPE and Excel 5 years
(The Trials book is supported by Biotronik)
December 13, 2019
JAA
New this week: A Dose-response Meta Analysis, stroke after MitraClip and more
December 10, 2019
Editorial
The challenge of innovation for the (interventional?) cardiology world
December 6, 2019
Guidance Papers
Guidelines, consensus & position papers
April 9, 2019
Editorial
2019 – A leap year for valvular heart disease
(Course directors PCR London Valves 2019)
November 15, 2019
JAA
Last week's JAA's: EXTREME Study, Stent Optimization and more
December 3, 2019